Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals

Detalhes bibliográficos
Autor(a) principal: Almeida, Nathália Alves Araujo de
Data de Publicação: 2019
Outros Autores: Barros, José Junior França de, Campos, Letícia Bomfim, Spitz, Natália, Brandão, Carlos Eduardo, Santana, Catarina Góis de, Paula, Vanessa Salete de
Tipo de documento: Artigo de conferência
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/32819
Resumo: Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
id CRUZ_b0b31a0f6a1cbbe24c3cb9b2834137e8
oai_identifier_str oai:www.arca.fiocruz.br:icict/32819
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Almeida, Nathália Alves Araujo deBarros, José Junior França deCampos, Letícia BomfimSpitz, NatáliaBrandão, Carlos EduardoSantana, Catarina Góis dePaula, Vanessa Salete de2019-04-29T13:00:41Z2019-04-29T13:00:41Z2019ALMEIDA, N. A. A. et al. Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p. 167.https://www.arca.fiocruz.br/handle/icict/3281910.35259/isi.sact.2019_32819Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Universidade Federal do Estado do Rio de Janeiro. Hospital Universitário Gaffrée e Guinle. Serviço de Gastroenterologia. Rio de Janeiro, RJ, Brasil.Universidade Federal do Estado do Rio de Janeiro. Hospital Universitário Gaffrée e Guinle. Serviço de Gastroenterologia. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.engFiocruz/Instituto de Tecnologia em ImunobiológicosHepatite B ocultaAntivirais orais de ação diretaHepatite COccult hepatitis BOral direct acting antiviralsHepatitis CHepatite BHepatite CPrevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antiviralsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/32819/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALORT_14.pdfapplication/pdf49571https://www.arca.fiocruz.br/bitstream/icict/32819/2/ORT_14.pdf1c582b6c75ae2af33442d8bf5ba6e5b5MD52TEXTORT_14.pdf.txtORT_14.pdf.txtExtracted texttext/plain3410https://www.arca.fiocruz.br/bitstream/icict/32819/3/ORT_14.pdf.txt114cb627c879f5b27f463ce47ba00cf6MD53icict/328192023-04-26 16:59:12.612oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-26T19:59:12Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals
title Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals
spellingShingle Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals
Almeida, Nathália Alves Araujo de
Hepatite B oculta
Antivirais orais de ação direta
Hepatite C
Occult hepatitis B
Oral direct acting antivirals
Hepatitis C
Hepatite B
Hepatite C
title_short Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals
title_full Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals
title_fullStr Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals
title_full_unstemmed Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals
title_sort Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals
author Almeida, Nathália Alves Araujo de
author_facet Almeida, Nathália Alves Araujo de
Barros, José Junior França de
Campos, Letícia Bomfim
Spitz, Natália
Brandão, Carlos Eduardo
Santana, Catarina Góis de
Paula, Vanessa Salete de
author_role author
author2 Barros, José Junior França de
Campos, Letícia Bomfim
Spitz, Natália
Brandão, Carlos Eduardo
Santana, Catarina Góis de
Paula, Vanessa Salete de
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Almeida, Nathália Alves Araujo de
Barros, José Junior França de
Campos, Letícia Bomfim
Spitz, Natália
Brandão, Carlos Eduardo
Santana, Catarina Góis de
Paula, Vanessa Salete de
dc.subject.other.pt_BR.fl_str_mv Hepatite B oculta
Antivirais orais de ação direta
Hepatite C
topic Hepatite B oculta
Antivirais orais de ação direta
Hepatite C
Occult hepatitis B
Oral direct acting antivirals
Hepatitis C
Hepatite B
Hepatite C
dc.subject.en.pt_BR.fl_str_mv Occult hepatitis B
Oral direct acting antivirals
Hepatitis C
dc.subject.decs.pt_BR.fl_str_mv Hepatite B
Hepatite C
description Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
publishDate 2019
dc.date.accessioned.fl_str_mv 2019-04-29T13:00:41Z
dc.date.available.fl_str_mv 2019-04-29T13:00:41Z
dc.date.issued.fl_str_mv 2019
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv ALMEIDA, N. A. A. et al. Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p. 167.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/32819
dc.identifier.doi.none.fl_str_mv 10.35259/isi.sact.2019_32819
identifier_str_mv ALMEIDA, N. A. A. et al. Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p. 167.
10.35259/isi.sact.2019_32819
url https://www.arca.fiocruz.br/handle/icict/32819
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/32819/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/32819/2/ORT_14.pdf
https://www.arca.fiocruz.br/bitstream/icict/32819/3/ORT_14.pdf.txt
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
1c582b6c75ae2af33442d8bf5ba6e5b5
114cb627c879f5b27f463ce47ba00cf6
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008824175427584

Registros relacionados